Categories

Meta

Recent Posts

StemCells initiates HuCNS-SC advance clinical go someone is concerned Batten ailment in children

Posted in Child Health on October 28th, 2010

StemCells, Inc. (Nasdaq:STEM) announced today that it has initiated a in the second place clinical woe of its HuCNS-SC® result aspirant (purified charitable neural cut back on resist cells) in neuronal ceroid lipofuscinosis (NCL, also ordinarily referred to as Batten complaint, a inevitable neurodegenerative disease in children. The affliction is designed to approximate the shelter and premonitory efficacy of the cells in patients with either Read the rest of this entry »

Coadministration of INTUNIV tablets with impulse reduces ADHD symptoms

Posted in Medical Condition on October 28th, 2010

Shire plc (LSE: SHP, Nasdaq: SHPGY), the extensive specialty biopharmaceutical convention, today presented examination results of once-daily INTUNIV™ (guanfacine) Extended-Release Tablets, coadministered with stimulants in children and adolescents diagnosed with Notoriety Loss Hyperactivity Clutter (ADHD) who had suboptimal effect to treatment with a long-acting drive matchless.  At bookwork extent feature, patients receiving INTUNIV coadministered Read the rest of this entry »

Non-distressed matrimony helps improve well-being reputation in the course of RA patients

Posted in Medical Condition on October 27th, 2010

Rheumatoid arthritis is a afflictive and debilitating train, but a over reported in The Tabloid of Pang, published especially the American Torture The public, www.ampainsoc.org, shows that being in a strongly-worded, non-distressed amalgamation is associated with experiencing less injure and enjoying greater functioning and dignity of living.

Researchers conducting a multicenter look at involving 255 patients examined the relationships Read the rest of this entry »

Momenta receives certificate of invention fitted methods to rank enoxaparin

Posted in Medical Patent on October 27th, 2010

Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology business specializing in the characterization and engineering of complex drugs, announced today that the U.S. Unmistakeable and Trademark Bit has issued U.S. Charter No. 7,816,144, entitled "Evaluating Mixtures of Shaky Molecular Albatross Heparins By way of Confine Profiles or Gyve Mapping". The trade mark includes claims to methods of analyzing and processing enoxaparin Read the rest of this entry »

VCA Clinical Sisterhood awarded championing epithelial ovarian cancer exploration

Posted in Medical Research on October 27th, 2010

Dr Clare Scott from the Walter and Eliza Lecture-hall Pioneer in Melbourne, Australia, has been awarded a Victorian Cancer Intermediation (VCA) Clinical Order to army scrutinize into an assertive and extremely mortal feather of ovarian cancer.

Epithelial ovarian cancer, which is ground in the cubicle lining (epithelium) of the ovary, accounts owing 90 per cent of ovarian tumours. Though, epithelial ovarian cancer is however unprofessionally Read the rest of this entry »

Rockwell receives U.S. control representing SFP formulation

Posted in Medical Patent on October 27th, 2010

Rockwell Medical (Nasdaq:RMTI), a fully-integrated biopharmaceutical assembly oblation innovative products and services targeting end-stage renal plague (ESRD), lasting kidney murrain (CKD), and iron deficiency anemia, announced today that it has received recognize from the U.S. Unmistakable and Trademark Corporation representing tangible issuance on its proprietary GMP formulation benefit of Soluble Ferric Pyrophosphate (SFP), the Company’s Read the rest of this entry »

USAID announces FIRE: Haleness innovators

Posted in Medical Research on October 27th, 2010

The U.S. Intermediation as regards Global Phenomenon (USAID), NASA, NIKE, Inc. and the U.S. Trust in of Governmental are on top of the world to betoken those selected to participate in the LAUNCH:Health Forum. The innovators selected whim participate in an conclusion at NASA’s Kennedy Spaciousness Center in Florida October 30-31, followed instanter in general the found of the Array Commute Recognition on November 1.

The notion behind Read the rest of this entry »

Brand-new British rethink reports on IMRT psychotherapy after prostate cancer treatment

Posted in Medical Condition on October 27th, 2010

A renewed British rehashing of existing check in suggests that while a newer model of shedding as a replacement for the treatment of prostate cancer does not remedy patients continue without longer compared to an older transcribe – at least when compare favourably with doses are accepted − it does arise to reset gastrointestinal side effects.

The newer specimen of shedding, known as intensity-modulated radiotherapy, has adorn come Read the rest of this entry »

Lifestyle intervention programs follow in pithy charge reduction repayment for overweight and severly gross adults

Posted in Medical Research on October 27th, 2010

Lifestyle interventions, including medical man occupation and structured mass annihilation programs, can fruit in outstanding mass impairment notwithstanding overweight, heavy and tyrannically paunchy adults, according to two reports that were posted online October 9 during JAMA. The studies and accompanying editorials were made within reach beginning online to come with the offering of these papers at the 28th Annual Orderly Converging of the Read the rest of this entry »

Boehringer Ingelheim and MacroGenics begin extensive antibody-based therapeutics pact

Posted in Medical Research on October 27th, 2010

Boehringer Ingelheim and MacroGenics today jointly announced that they oblige entered into a pandemic affinity to identify, bring out and commercialize antibody-based therapeutics which may term multiple healing areas, including immunology, oncology, respiratory, cardiometabolic and communicable diseases.  These developmental downer candidates ordain be based on MacroGenics’ Dual-Affinity Re-Targeting (DART™) plank and disposition be directed Read the rest of this entry »